리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 02월
페이지 정보:영문 268 Pages
라이선스 & 가격 (부가세 별도)
한글목차
마네킹 기반 시뮬레이션 세계 시장, 2030년까지 61억 달러에 달할 전망
2024년에 26억 달러로 추정되는 마네킹 기반 시뮬레이션 세계 시장은 2024-2030년 동안 연평균 15.2%로 성장하여 2030년에는 61억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 환자 시뮬레이터는 CAGR 14.8%를 기록하여 분석 기간이 끝날 때까지 41억 달러에 달할 것으로 예상됩니다. 기타 제품 유형 부문의 성장률은 분석 기간 동안 CAGR 16.1%로 추정됩니다.
미국 시장 11억 달러로 추정, 중국은 CAGR 17.6%로 성장 전망
미국의 마네킹 기반 시뮬레이션 시장은 2024년 11억 달러 규모로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 3억 4,740만 달러의 시장 규모에 도달할 것으로 예상되며, 2024-2030년 분석 기간 동안 CAGR은 17.6%에 달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 12.1% 및 13.6%의 CAGR을 기록할 것으로 예측됩니다. 유럽에서는 독일이 약 13.3%의 CAGR로 성장할 것으로 예상됩니다.
세계 마네킹 기반 시뮬레이션 시장 - 주요 동향 및 촉진요인 정리
마네킹 기반 시뮬레이션은 의료 교육 및 훈련에 필수적인 요소로, 의료 전문가가 연습하고 기술을 연마할 수 있는 현실적이고 통제된 환경을 제공합니다. 이러한 시뮬레이션에는 호흡, 심장 박동, 언어적 의사소통 등 인간의 생리적 반응을 모방할 수 있는 고충실도 마네킹이 사용됩니다. 마네킹 기반 시뮬레이션을 통해 환자의 안전을 위협하지 않고 복잡한 의료 절차를 연습하고, 응급상황에 대한 대응을 연습하며, 임상적 의사결정 기술을 향상시킬 수 있습니다. 의료 절차가 고도화되고 고도로 숙련된 의료 서비스 제공자의 필요성이 증가함에 따라 이 훈련 방법의 중요성이 점점 더 커지고 있습니다.
의료 교육에서 마네킹 기반 시뮬레이션의 채택은 기술의 발전과 그 효과에 대한 인식으로 확대되고 있습니다. 최신 시뮬레이션 마네킹은 매우 정교하며, 다양한 질병 상태와 시나리오를 실제와 같은 정확도로 시뮬레이션할 수 있습니다. 이 기술은 귀중한 실전 경험을 제공하며, 훈련생은 숙달될 때까지 반복적으로 기술을 연습할 수 있습니다. 또한, 마네킹을 이용한 시뮬레이션은 다학제간 교육에도 활용되어 의료 전문가들 간의 팀워크와 소통을 촉진합니다. 이러한 의학 교육에 대한 종합적인 접근 방식은 이론적 지식과 실무 기술의 격차를 해소하고, 궁극적으로 환자의 예후를 개선하는 데 도움이 됩니다.
마네킹 기반 시뮬레이션 시장의 성장은 몇 가지 요인에 의해 이루어지고 있습니다. 첫째, 의료 절차가 복잡해지고 정확성과 능력이 요구됨에 따라 시뮬레이션 기반 교육이 필수적으로 요구되고 있습니다. 둘째, 현실감과 인터랙티비티의 향상을 포함한 마네킹 기술의 발전으로 훈련의 경험과 성과가 향상되고 있습니다. 셋째, 환자 안전과 의료 과실 감소에 대한 관심이 높아지면서 의료 커리큘럼에 시뮬레이션 교육이 널리 채택되고 있습니다. 마지막으로, 임상 교육 시설의 지속적인 부족과 효율적이고 확장 가능한 교육 솔루션에 대한 요구는 마네킹 기반 시뮬레이션에 대한 수요를 더욱 증가시키고 있습니다. 이러한 요인들이 결합되어 마네킹 기반 시뮬레이션 시장의 지속적인 확장과 혁신을 보장하고 있습니다.
부문
제품 유형(환자 시뮬레이터, 기타 제품 유형), 최종사용자(대학, 병원, 기타 최종사용자)
조사 대상 기업 사례(총 55건)
Moog, Inc.
Laerdal Medical AS
Ambu A/S
3B Scientific GmbH
Cardionics
DentalEZ, Inc.
Gaumard Scientific Co., Inc.
IngMar Medical
Kyoto Kagaku Co., Ltd.
Mentice AB
CAE Healthcare
Adam Rouilly Ltd.
Global Technologies
KOKEN CO., LTD.
LifeCast Body Simulation Ltd.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Mannequin-Based Simulation Market to Reach US$6.1 Billion by 2030
The global market for Mannequin-Based Simulation estimated at US$2.6 Billion in the year 2024, is expected to reach US$6.1 Billion by 2030, growing at a CAGR of 15.2% over the analysis period 2024-2030. Patient Simulators, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Other Product Types segment is estimated at 16.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 17.6% CAGR
The Mannequin-Based Simulation market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.4 Million by the year 2030 trailing a CAGR of 17.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.1% and 13.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.3% CAGR.
Global Mannequin-Based Simulation Market - Key Trends & Drivers Summarized
Mannequin-based simulation is a vital component in medical education and training, providing a realistic and controlled environment for healthcare professionals to practice and hone their skills. These simulations use high-fidelity mannequins that can mimic human physiological responses, such as breathing, heartbeats, and even verbal communication. Mannequin-based simulation allows for the rehearsal of complex medical procedures, the practice of emergency responses, and the improvement of clinical decision-making skills without risking patient safety. This method of training has become increasingly important as medical procedures become more sophisticated and the need for highly skilled healthcare providers grows.
The adoption of mannequin-based simulation in medical training has grown due to advancements in technology and the recognition of its effectiveness. Modern simulation mannequins are highly advanced, capable of simulating a wide range of medical conditions and scenarios with realistic accuracy. This technology provides invaluable hands-on experience, enabling trainees to practice and repeat procedures until they achieve proficiency. Furthermore, mannequin-based simulations are used for interdisciplinary training, promoting teamwork and communication among healthcare professionals. This holistic approach to medical education helps bridge the gap between theoretical knowledge and practical skills, ultimately leading to better patient outcomes.
The growth in the mannequin-based simulation market is driven by several factors. Firstly, the increasing complexity of medical procedures and the need for precision and competence have made simulation-based training essential. Secondly, advancements in mannequin technology, including improved realism and interactivity, have enhanced the training experience and outcomes. Thirdly, there is a growing emphasis on patient safety and the reduction of medical errors, which has led to the widespread adoption of simulation training in medical curricula. Lastly, the ongoing shortage of clinical training sites and the need for efficient, scalable training solutions have further propelled the demand for mannequin-based simulation. These factors collectively ensure the continued expansion and innovation within the mannequin-based simulation market.
SCOPE OF STUDY:
The report analyzes the Mannequin-Based Simulation market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Patient Simulators, Other Product Types); End-Use (Academics, Hospitals, Other End-Uses)
Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.
Select Competitors (Total 55 Featured) -
Moog, Inc.
Laerdal Medical AS
Ambu A/S
3B Scientific GmbH
Cardionics
DentalEZ, Inc.
Gaumard Scientific Co., Inc.
IngMar Medical
Kyoto Kagaku Co., Ltd.
Mentice AB
CAE Healthcare
Adam Rouilly Ltd.
Global Technologies
KOKEN CO., LTD.
LifeCast Body Simulation Ltd.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Economic Update
COVID-19 Impact on Mannequin-Based Simulation
Mannequin - A Prelude
Simulation Based Education
Nursing Education Embraces Simulation-based Learning in a Major Way
Mannequin-based Simulation: An Integral Part of Medical Simulation Market
Global Mannequin-based Simulation Market Set to Witness Significant Growth
Growth Drivers
Increasing Focus on Patient Safety
Limited Access to Live Patients Drives Market for Simulation
Simulation in Healthcare Enables Cost Reduction
Technology Revolution Drives Demand for Simulation
Affordability & Rising Implementation to Boost Demand
Developed Regions: Primary Revenue Contributors
Developing Regions Offer High Growth Potential for Mannequin-based Simulation
Patient Simulators Lead the Mannequin-based Simulation Market
Competition
Mannequin-Based Simulation - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increase in Surgeries Augurs Well for Market Growth
Global Surgical Procedure Volume by Procedure Type
Rise in Number of Surgeries & Shortage of Surgeons Drive Use of Mannequin-based Simulation for Surgeon Education and Training
Surgical Backlog & Surgeon Shortages: A Harrowing Situation
Cancer Surgery Demand Surges Amid Surgeon Shortage
Mannequin-based Simulation to the Rescue
As the Number of Surgeries Performed Globally Increase, the Need for Well Trained Surgeons Becomes Acute, Strengthening the Business Case for Mannequin-based Simulation: Global Market for General Surgery (In US$ Billion) for Years 2018, 2020, 2022, 2024, 2026 and 2028
Virtual Simulation and High-Fidelity Mannequin Simulation for Recognizing Critical Events
High-fidelity Mannequins
Advanced Mannequins Imitate Human Reactions
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Mannequin-based Simulation for Nursing Schools
Cardiology, a Promising Field for Medical Animation/Simulation
Simulation Benefits Interventional Cardiology
Mannequins Gain Traction in Military Medical Training
Minimally-invasive Procedures Necessitate Simulation-based Training
Robot-assisted Surgical Simulation Training Gaining Significance
Simulation Training Preferred for Cataract Surgery
Surgical Simulation Gets Notable Makeover with Influx of Innovative Approaches
Surgical Simulation: The History & Evolution
Existing Surgical Simulation Models
Continuing Advances Pave Way for Versatile & Realistic Surgical Simulators
Innovations Set to Take Surgical Simulation to Next Level
Select Innovations
Learning Theories Guiding Development of Simulation-based Education
Areas where Under Graduate Nursing Education Simulation is Most Used
Virtual Simulations for UG Nursing Programs
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Mannequin-Based Simulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Patient Simulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 21: USA Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: USA 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: USA 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: Canada 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: Canada 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
TABLE 32: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: Japan 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: Japan 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
TABLE 38: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: China Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: China 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: China 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: Europe 15-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Europe 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Europe 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
TABLE 53: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: France Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: France 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: France 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
TABLE 59: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Germany 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Germany 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Italy 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Italy 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
TABLE 71: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: UK Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: UK 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: UK 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: Rest of Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: Rest of Europe 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Rest of Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Rest of Europe 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: Asia-Pacific Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Asia-Pacific 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Asia-Pacific Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Asia-Pacific 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 89: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Rest of World Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Rest of World 15-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2015, 2025 & 2030
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of World Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of World 15-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030